Sjogren's syndrome is an autoimmune disease that causes dryness in the mouth and eyes due to lack of tears and saliva. The prevalence of this syndrome is increasing with rising environmental pollution and other factors. This has increased the demand for medications managing dry eyes and mouth, tear and saliva substitutes, and devices monitoring dryness levels associated with Sjogren’s syndrome.
The global Sjogren’s Syndrome Market is estimated to be valued at US$ 242.81 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of Sjogren's syndrome driven by environmental factors has accelerated the demand for therapeutics and diagnostic tests for early detection and management of the disease. The rising awareness about Sjogren's syndrome symptoms and available treatment options has further propelled the market growth. Various government and non-profit organizations are funding research on developing novel drug formulations and diagnostic biomarkers which will possibly drive the market during the forecast period.
Segment Analysis
The global Sjogren's Syndrome market is dominated by the primary Sjogren's syndrome segment which accounts for nearly 70% share of the overall market. Primary Sjogren's syndrome arises independently without any other connective tissue disease and is characterized by dry eyes and dry mouth along with symptoms of fatigue, joint pain and dryness in other parts of the body.The high prevalence and extensive manifestation of symptoms have made primary Sjogren's syndrome the dominating sub-segment in the market.
Key Takeaways
The global Sjogren’s Syndrome Market Share is expected to witness high growth during the forecast period of 2023 to 2030. The global Sjogren’s Syndrome Market is estimated to be valued at US$ 242.81 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030.
Regional analysis
North America accounts for the largest share in the global Sjogren's Syndrome market owing to high awareness levels regarding the disease, established healthcare infrastructure and presence of key market players in the region. Europe is the second largest regional market. However, Asia Pacific is expected to witness the fastest growth during the forecast period due to growing geriatric population, improving access to healthcare services and increasing expenditure on healthcare.
Key players
Key players operating in the Sjogren's Syndrome market are Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation.
Get More Insights On This Topic: https://www.pressreleasebulletin.com/the-global-sjogrens-syndrome-market-driven-by-increasing-prevalence-of-autoimmune-disorders/
The Global Sjogren's Syndrome market 2020-2026 report gives complete information concerning the market, size, commercialization perspectives, and revenue forecast of the business.
The global Sjogren's Syndrome market report covers the major product & application categories & segments.
The Global Sjogren's Syndrome research report Forecast provides a comprehensive outline of the business with the expectations of the development and revenue.The analysis is assessed with the assistance of detailed market surveying.
The global Sjogren's Syndrome industry report has been assembled using primary and secondary research methods, which provide precise and accurate comprehension.
The client gets wide knowledge and deep perceptive of Sjogren's Syndrome restraints, distinct drivers, and factors impacting the industry.Detailed TOC along with also Charts & Tables of Sjogren's Syndrome Market Research Report accessible at: https://www.futuristicreports.com/request-sample/55981Key Players Mentioned at the Sjogren's Syndrome Market Report:AstraZenecaarGentis Pharmaceuticals, LLCKissei Pharmaceutical Co., Ltd.EisaiAmgenPfizer Inc.Otsuka Pharmaceutical Co. LtdBiogenSanten Pharmaceutical Co. LtdF.
Hoffmann-La Roche AGAstellas Pharma Inc.Bristol-Myers SquibbOno PharmaceuticalCinkate Corp.Novartis International AGNicox S.ASanofi S.A.Allergan IncGenentech, Inc.,MedImmune, LLCDaiichi SankyoHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd,This Sjogren's Syndrome report analysis attainability with a goal of instructive new players concerning the progressions within the market.
